195 related articles for article (PubMed ID: 17932222)
41. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
[TBL] [Abstract][Full Text] [Related]
42. TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain.
Kawamoto T; Ii M; Kitazaki T; Iizawa Y; Kimura H
Eur J Pharmacol; 2008 Apr; 584(1):40-8. PubMed ID: 18299127
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression.
Medvedev AE; Kopydlowski KM; Vogel SN
J Immunol; 2000 Jun; 164(11):5564-74. PubMed ID: 10820230
[TBL] [Abstract][Full Text] [Related]
44. Association of TLR4 (D299G, T399I), TLR9 -1486T>C, TIRAP S180L and TNF-α promoter (-1031, -863, -857) polymorphisms with risk for systemic lupus erythematosus among South Indians.
Rupasree Y; Naushad SM; Rajasekhar L; Uma A; Kutala VK
Lupus; 2015 Jan; 24(1):50-7. PubMed ID: 25182168
[TBL] [Abstract][Full Text] [Related]
45. Increased lipopolysaccharide sensitivity in alcoholic fatty livers is independent of leptin deficiency and toll-like receptor 4 (TLR4) or TLR2 mRNA expression.
Romics L; Mandrekar P; Kodys K; Velayudham A; Drechsler Y; Dolganiuc A; Szabo G
Alcohol Clin Exp Res; 2005 Jun; 29(6):1018-26. PubMed ID: 15976528
[TBL] [Abstract][Full Text] [Related]
46. Inhibiting the toll-like receptor 4 Toll/interleukin-1 receptor domain protects against hepatic warm ischemia and reperfusion injury in mice.
Meimei H; Dejin M; Erzhen C; Minmin S; Songyao J; Jianfang L; Hao C
Crit Care Med; 2014 Feb; 42(2):e123-31. PubMed ID: 24231763
[TBL] [Abstract][Full Text] [Related]
47. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
[TBL] [Abstract][Full Text] [Related]
48. Data-Driven Modeling Identifies TIRAP-Independent MyD88 Activation Complex and Myddosome Assembly Strategy in LPS/TLR4 Signaling.
Li X; Zhong CQ; Yin Z; Qi H; Xu F; He Q; Shuai J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32357531
[TBL] [Abstract][Full Text] [Related]
49. Influence of genetic variations in TLR4 and TIRAP/Mal on the course of sepsis and pneumonia and cytokine release: an observational study in three cohorts.
Kumpf O; Giamarellos-Bourboulis EJ; Koch A; Hamann L; Mouktaroudi M; Oh DY; Latz E; Lorenz E; Schwartz DA; Ferwerda B; Routsi C; Skalioti C; Kullberg BJ; van der Meer JW; Schlag PM; Netea MG; Zacharowski K; Schumann RR
Crit Care; 2010; 14(3):R103. PubMed ID: 20525286
[TBL] [Abstract][Full Text] [Related]
50. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
51. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4.
Baumgarten G; Knuefermann P; Nozaki N; Sivasubramanian N; Mann DL; Vallejo JG
J Infect Dis; 2001 Jun; 183(11):1617-24. PubMed ID: 11343210
[TBL] [Abstract][Full Text] [Related]
52. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock.
Prince JM; Levy RM; Yang R; Mollen KP; Fink MP; Vodovotz Y; Billiar TR
J Am Coll Surg; 2006 Mar; 202(3):407-17. PubMed ID: 16500244
[TBL] [Abstract][Full Text] [Related]
53. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4).
Qureshi ST; Larivière L; Leveque G; Clermont S; Moore KJ; Gros P; Malo D
J Exp Med; 1999 Feb; 189(4):615-25. PubMed ID: 9989976
[TBL] [Abstract][Full Text] [Related]
54. Modulation of Toll-interleukin 1 receptor mediated signaling.
Li X; Qin J
J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
[TBL] [Abstract][Full Text] [Related]
55. CYP3A-dependent drug metabolism is reduced in bacterial inflammation in mice.
Gandhi AS; Guo T; Shah P; Moorthy B; Chow DS; Hu M; Ghose R
Br J Pharmacol; 2012 Aug; 166(7):2176-87. PubMed ID: 22394353
[TBL] [Abstract][Full Text] [Related]
56. Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period.
Harju K; Ojaniemi M; Rounioja S; Glumoff V; Paananen R; Vuolteenaho R; Hallman M
Pediatr Res; 2005 May; 57(5 Pt 1):644-8. PubMed ID: 15718365
[TBL] [Abstract][Full Text] [Related]
57. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling.
Kagan JC; Medzhitov R
Cell; 2006 Jun; 125(5):943-55. PubMed ID: 16751103
[TBL] [Abstract][Full Text] [Related]
58. β-Caryophyllene alleviates D-galactosamine and lipopolysaccharide-induced hepatic injury through suppression of the TLR4 and RAGE signaling pathways.
Cho HI; Hong JM; Choi JW; Choi HS; Hwan Kwak J; Lee DU; Kook Lee S; Lee SM
Eur J Pharmacol; 2015 Oct; 764():613-621. PubMed ID: 26254779
[TBL] [Abstract][Full Text] [Related]
59. Acylation determines the toll-like receptor (TLR)-dependent positive versus TLR2-, mannose receptor-, and SIGNR1-independent negative regulation of pro-inflammatory cytokines by mycobacterial lipomannan.
Doz E; Rose S; Nigou J; Gilleron M; Puzo G; Erard F; Ryffel B; Quesniaux VF
J Biol Chem; 2007 Sep; 282(36):26014-25. PubMed ID: 17617634
[TBL] [Abstract][Full Text] [Related]
60. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
